TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments
  • Shareholders Foundation monitors Class Action Investigations, Cases, and Class Action Settlements.
    Learn More >>>
  • Create Notifications and monitor one Case or multiple Cases. Or submit your entire portfolio! Learn More >>>

Pharmaceutical Product Development, Inc. Buyout Under Investor Investigation

  • If you purchased shares of Pharmaceutical Product Development, Inc. (NASDAQ: PPDI) prior to the announcement and currently hold those shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

San Diego, Oct. 03, 2011 (Shareholders Foundation) -- The announcement that Pharmaceutical Product Development agreed to be acquired by affiliates of The Carlyle Group and Hellman & Friedman for $33.25 per PPDI share prompted an investigation on behalf of investors of Pharmaceutical Product Development, Inc. (NASDAQ:PPDI)) concerning whether the offer to acquire Pharmaceutical Pro...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)